EyeQ Tech review EyeQ Tech EyeQ Tech tuyển dụng review công ty eyeq tech eyeq tech giờ ra sao EyeQ Tech review EyeQ Tech EyeQ Tech tuyển dụng crab exports crab exports crab exports crab export crab export crab export ca mau crabs crab industry crab farming crab farming crab farming crab farming crab farming crab farming crab farming crab farming crab farming

Breaking News

Trump's attorney general pick Matt Gaetz withdraws from consideration
Business

Dow loses 390 points after vaccine-fueled rally on Wall Street

By
Noah Manskar
Published May 19, 2020
Updated May 19, 2020, 4:20 p.m. ET

A US stock rally stumbled on Tuesday as investors reined in their optimism about a promising coronavirus vaccine.

The Dow Jones industrial average dipped 390.51 points, or  24,206.86, giving back some of its 900-point Monday rally. The S&P 500 dropped 1.1 percent after posting its best day in six weeks on Monday, while the tech-heavy Nasdaq lost 0.5 percent.

The muted movements marked a pullback from Wall Street’s enthusiasm about progress toward a COVID-19 vaccine from biotech firm Moderna.

While a vaccine is key to reopening the global economy after a pandemic-induced shutdown, experts said investors’ excitement was exaggerated given the small scale of Moderna’s early trial, which had only 45 participants.

“The market’s … had that pattern here for the last month of these really sharp up and down moves, so you’re encouraging a lot of people at the margin to try to play that a little bit,” said Jim Paulsen, chief investment strategist at the Leuthold Group.

“Given the exceedingly long runway for a vaccine to be made available en masse and the short-term nature of news trading, it makes sense for some traders to fade the move based on previous disappointments,” said Stephen Innes, chief global market strategist at AxiCorp.

The choppy session came as Federal Reserve chairman Jerome Powell and Treasury Secretary Steven Mnuchin testified before the US Senate Banking Committee on their response to the coronavirus crisis.

Powell has thrown cold water on hopes for a quick rebound from the economic downturn the pandemic has caused, saying the recovery could stretch through the end of next year.

Wall Street is also getting pessimistic about the pace of the recovery even though the S&P has climbed more than 30 percent from its March low. Only 10 percent of professional investors expect a rapid “V-shaped” rebound amid concerns about a second wave of coronavirus infections, according to Bank of America’s fund manager survey for May.

“What the market wants to see is a viable recovery, meaning slow but steady,” said Quincy Krosby, chief market strategist for Prudential Financial. “This is the key — a recovery that is not thwarted by a second wave.”

With Post wires